{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T04:44:57Z","timestamp":1773549897869,"version":"3.50.1"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Different imaging techniques, such as echocardiography (ECHO) and CT, allow to assess aortic stenosis (AS) severity and could be used to study its progression. But only PET\/CT open opportunities to assess activity of valvular inflammation and calcification <jats:italic>in vivo<\/jats:italic>. The aim of this study was to assess prognostic value of valvular inflammation and calcification measured by <jats:sup>18<\/jats:sup>F-FDG and <jats:sup>18<\/jats:sup>F-NaF PET\/CT in patients with tricuspid (TAV) and bicuspid aortic valve (BAV).<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The study included 71 patients aged 40\u201370\u00a0years with mild, moderate and severe asymptomatic calcific AS. Patients were divided into two groups according to valve morphology: with BAV and TAV. All patients underwent standard ECHO, CT calcium scoring PET\/CT with <jats:sup>18<\/jats:sup>F-NaF and <jats:sup>18<\/jats:sup>F-FDG. All patients were evaluated during a follow-up visit with evaluation of ECHO parameters. (16.8 \u00b1 4.2\u00a0months).<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> TAV and BAV groups were comparable in AS severity by ECHO (peak aortic jet velocity (Vmax): 2.90 [2.60; 3.50] vs. 2.96 [2.55; 3.31]\u00a0m\/s, <jats:italic>p<\/jats:italic> = 0.83). TBR max <jats:sup>18<\/jats:sup>F-FDG did not vary in TAV and BAV patients (1.15 [1.06; 1.23] vs. 1.11 [1.03; 1.20], <jats:italic>p<\/jats:italic> = 0.39). Both groups did not differ in valvular calcification degree (Agatston score 1,058 [440; 1798] vs. 1,128 [533; 2,360], <jats:italic>p<\/jats:italic> = 0.55) and calcification activity assessed by <jats:sup>18<\/jats:sup>F-NaF uptake level (TBR max 1.50 [1.30; 1.78] vs. 1.48 [1.27; 1.83], <jats:italic>p<\/jats:italic> = 0.97). <jats:sup>18<\/jats:sup>F-NaF TBR max was associated with AS severity measured by Vmax in men and women with TAV (r = 0.54; <jats:italic>p<\/jats:italic> = 0.04 vs. r = 0.53; <jats:italic>p<\/jats:italic> = 0.03). In BAV group this relationship was true only in female patients (r = 0.1; <jats:italic>p<\/jats:italic> = 0.67 vs. r = 0.7; <jats:italic>p<\/jats:italic> = 0.0004). There was no association between Vmax and TBR max <jats:sup>18<\/jats:sup>F-FDG was revealed in TAV and BAV groups. During follow-up period, the most important positive predictors of AS progression in TAV obtained by multinomial logistic regression analysis were Vmax, and <jats:sup>18<\/jats:sup>F-NaF TBR. Whereas in BAV the highest predictive value showed model included age and Vmax.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold><jats:sup>18<\/jats:sup>F-NaF PET\/CT may be considered as the valuable predictor for hemodynamic progression of calcific AS in case of TAV. <jats:sup>18<\/jats:sup>F-FDG PET\/CT does not play a significant role to predict the AS progression.<\/jats:p>","DOI":"10.3389\/fphar.2022.909975","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T07:48:17Z","timestamp":1653378497000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Prediction of Aortic Stenosis Progression by 18F-FDG and 18F-NaF PET\/CT in Different Aortic Valve Phenotypes"],"prefix":"10.3389","volume":"13","author":[{"given":"Patimat","family":"Murtazalieva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darya","family":"Ryzhkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduard","family":"Malev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Zhiduleva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Moiseeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1161\/CIRCIMAGING.112.980052","article-title":"Sex Differences in Aortic Valve Calcification Measured by Multidetector Computed Tomography in Aortic Stenosis","volume":"6","author":"Aggarwal","year":"2013","journal-title":"Circ. Cardiovasc Imaging"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ejechocard\/jen303","article-title":"Echocardiographic Assessment of Valve Stenosis: EAE\/ASE Recommendations for Clinical Practice","volume":"10","author":"Baumgartner","year":"2009","journal-title":"Eur. J. Echocardiogr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.3389\/fphys.2018.01635","article-title":"Inflammation and Mechanical Stress Stimulate Osteogenic Differentiation of Human Aortic Valve Interstitial Cells","volume":"9","author":"Bogdanova","year":"2018","journal-title":"Front. Physiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e006760","DOI":"10.1161\/CIRCIMAGING.117.006760","article-title":"Risk Stratification of Severe Aortic Stenosis with Preserved Left Ventricular Ejection Fraction Using Peak Aortic Jet Velocity: An Outcome Study","volume":"10","author":"Bohbot","year":"2017","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"B5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.109.900027","article-title":"Effect of Lipid Lowering with Rosuvastatin on Progression of Aortic Stenosis: Results of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) Trial","volume":"121","author":"Chan","year":"2010","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.051052","article-title":"Assessment of Valvular Calcification and Inflammation by Positron Emission Tomography in Patients with Aortic Stenosis","volume":"3125","author":"Dweck","year":"2012","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1161\/CIRCIMAGING.113.001508","article-title":"18F-sodium Fluoride Uptake is a Marker of Active Calcification and Disease Progression in Patients with Aortic Stenosis","volume":"7","author":"Dweck","year":"2014","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"B8","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10654-014-9936-x","article-title":"Assessment of Risk Factors for Developing Incident Aortic Stenosis: the Troms\u00f8 Study","volume":"29","author":"Eveborn","year":"2014","journal-title":"Eur. J. Epidemiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1161\/ATVBAHA.116.307293","article-title":"Vascular Inflammation Evaluated by [18F]-Fluorodeoxyglucose-Positron Emission Tomography\/computed Tomography Is Associated with Endothelial Dysfunction","volume":"36","author":"Honda","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1161\/CIRCULATIONAHA.119.041080","article-title":"Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey","volume":"140","author":"Iung","year":"2019","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1161\/ATVBAHA.114.304015","article-title":"Carotid Plaque, Intima-Media Thickness, and Incident Aortic Stenosis: A Prospective Cohort Study","volume":"34","author":"Martinsson","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1136\/heartjnl-2014-307154","article-title":"Haemodynamic and Anatomic Progression of Aortic Stenosis","volume":"101","author":"Nguyen","year":"2015","journal-title":"Heart"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.121.053708","article-title":"Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial","volume":"143","author":"Pawade","year":"2021","journal-title":"Circulation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1161\/01.CIR.0000155623.48408.C5","article-title":"Frequency by Decades of Unicuspid, Bicuspid, and Tricuspid Aortic Valves in Adults Having Isolated Aortic Valve Replacement for Aortic Stenosis, with or without Associated Aortic Regurgitation","volume":"111","author":"Roberts","year":"2005","journal-title":"Circulation"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1093\/ehjci\/jex218","article-title":"Doppler Assessment of Aortic Stenosis: A 25-operator Study Demonstrating Why Reading the Peak Velocity is Superior to Velocity Time Integral","volume":"19","author":"Sacchi","year":"2018","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"B16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/ehjci\/jeaa068","article-title":"Effect of Bicuspid Aortic Valve Phenotype on Progression of Aortic Stenosis","volume":"21","author":"Shen","year":"2020","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"B17","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/s0735-1097(96)00563-3","article-title":"Clinical Factors Associated with Calcific Aortic Valve Disease. Cardiovascular Health Study","volume":"29","author":"Stewart","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.jacc.2006.05.076","article-title":"In Vivo 18F-fluorodeoxyglucose Positron Emission Tomography Imaging Provides a Noninvasive Measure of Carotid Plaque Inflammation in Patients","volume":"48","author":"Tawakol","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS Guidelines for the Management of Valvular Heart Disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur. Heart J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jss.2014.03.051","article-title":"Aortic Valve Calcification is Mediated by a Differential Response of Aortic Valve Interstitial Cells to Inflammation","volume":"190","author":"Venardos","year":"2014","journal-title":"J. Surg. Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.jacc.2017.01.025","article-title":"Association between Cardiovascular Risk Factors and Aortic Stenosis: The CANHEART Aortic Stenosis Study","volume":"69","author":"Yan","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jcmg.2021.01.017","article-title":"Aortic Stenosis Progression, Cardiac Damage, and Survival: Comparison between Bicuspid and Tricuspid Aortic Valves","volume":"14","author":"Yang","year":"2021","journal-title":"JACC Cardiovasc. Imaging"},{"key":"B23","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.athoracsur.2015.10.092","article-title":"Mechanical versus Bioprosthetic Aortic Valve Replacement in Middle-Aged Adults: A Systematic Review and Meta-Analysis","volume":"102","author":"Zhao","year":"2016","journal-title":"Ann. Thorac. Surg."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.jacc.2019.01.070","article-title":"Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients with Aortic Stenosis","volume":"73","author":"Zheng","year":"2019","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.909975\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T07:48:20Z","timestamp":1653378500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.909975\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,24]]},"references-count":24,"alternative-id":["10.3389\/fphar.2022.909975"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.909975","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,24]]},"article-number":"909975"}}